X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 2026-01-05 | LB | Landbridge Co LLC | Oil Royalty Traders | 2 | P - Purchase | $46.66 | +2,993 | 290,420 | +1% | +$139,656 | |||||
| 3 | 2026-01-05 | WBI | Waterbridge Infrastructure LLC | Oil & Gas Field Services | 3 | P - Purchase | $20.13 | +11,865 | 314,365 | +4% | +$238,844 | |||||
| 36 M | 2025-12-31 | TPVG | Triplepoint Venture Growth Bdc Corp. | Closed-End Funds | 2 | P - Purchase | $6.34 | +2,541,490 | 4,220,590 | +151% | +$16,105,906 | |||||
| 5 M | 2025-12-31 | HYPD | Hyperion Defi, Inc. | Pharmaceutical Preparations | 4 | P - Purchase | $3.23 | +189,204 | 698,493 | +37% | +$611,458 | |||||
| 2 M | 2025-11-06 | LTC | Ltc Properties Inc | Real Estate Investment Trusts | 2 | P - Purchase | $34.80 | +15,000 | 55,460 | +37% | +$521,960 | |||||
| 3 M | 2025-12-31 | LSAK | Lesaka Technologies Inc | Functions Related to Depository Banking | 2 | P - Purchase | $4.99 | +1,830,500 | 2,575,615 | +246% | +$9,130,204 | |||||
| 2 M | 2025-12-30 | MDBH | Mdb Capital Holdings, LLC | Finance Services | 2 | P - Purchase | $3.41 | +16,935 | 264,868 | +7% | +$57,683 | |||||
| 4 | 2025-12-19 | IMNM | Immunome Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $21.22 | +68,518 | 896,547 | +8% | +$1,453,958 | |||||
| 4 | 2025-12-29 | NKE | Nike, Inc. | Rubber & Plastics Footwear | 4 | P - Purchase | $59.77 | +91,229 | 413,328 | +28% | +$5,452,641 | |||||
| 3 | 2025-11-10 | AROW | Arrow Financial Corp | National Commercial Banks | 3 | P - Purchase | $30.85 | +6,299 | 92,490 | +7% | +$194,310 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-05 | LB | Landbridge Co LLC | Bolling Harrison Fenner | See Remarks | P - Purchase | $46.84 | +850 | 66,874 | +1% | +$39,814 | ||||||
2026-01-05 | WBI | Waterbridge Infrastructure LLC | Long Jason Thomas | CEO | P - Purchase | $19.84 | +5,000 | 142,500 | +4% | +$99,200 | ||||||
2026-01-05 | WBI | Waterbridge Infrastructure LLC | Bolling Harrison Fenner | See Remarks | P - Purchase | $19.98 | +2,000 | 72,000 | +3% | +$39,960 | ||||||
2026-01-06 | WBI | Waterbridge Infrastructure LLC | Reitz Michael Howard Jr | See Remarks | P - Purchase | $20.49 | +4,865 | 99,865 | +5% | +$99,684 | ||||||
2026-01-05 | LB | Landbridge Co LLC | Long Jason Thomas | See Remarks | P - Purchase | $46.59 | +2,143 | 223,546 | +1% | +$99,842 | ||||||
| M | 2026-01-02 | NAVN | Navan, Inc. | Andreessen Horowitz Lsv Fund I, L.P. | 10% | P - Purchase | $16.31 | +976,975 | 28,172,339 | +4% | +$15,938,867 | |||||
| M | 2026-01-02 | NAVN | Navan, Inc. | Andreessen Horowitz Lsv Fund Iii, L.P. | 10% | P - Purchase | $16.31 | +976,975 | 28,172,339 | +4% | +$15,938,867 | |||||
| M | 2026-01-02 | NAVN | Navan, Inc. | Andreessen Horowitz Fund V, L.P. | 10% | P - Purchase | $16.31 | +976,975 | 28,172,339 | +4% | +$15,938,867 | |||||
| M | 2026-01-02 | NAVN | Navan, Inc. | Horowitz Benjamin A | Dir, 10% | P - Purchase | $16.31 | +976,975 | 28,172,339 | +4% | +$15,938,867 | |||||
| M | 2026-01-02 | SLGL | Sol-Gel Technologies Ltd. | Opaleye Management Inc. | 10% | P - Purchase | $42.00 | +2,592 | 457,331 | +1% | +$108,858 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-02 | RCKT | Rocket Pharmaceuticals, Inc. | Bjork Elisabeth | Dir | P - Purchase | $3.44 | +10,000 | 50,000 | +25% | +$34,400 | ||||||
2025-12-29 | NNUP | Nocopi Technologies Inc/Md/ | Westenburg Kevin Camerer | Pres | P - Purchase | $1.50 | +33,333 | 200,533 | +20% | +$50,000 | ||||||
2025-12-31 | HYPD | Hyperion Defi, Inc. | Knox David R. | CFO | P - Purchase | $3.59 | +27,950 | 327,950 | +9% | +$100,341 | ||||||
| M | 2025-12-29 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.03 | +148,502 | 647,505 | +30% | +$153,081 | |||||
2025-12-31 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,865,651 | +3% | +$47,275 | ||||||
2025-12-31 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $5.00 | +1,800,000 | 2,325,115 | +343% | +$9,000,000 | ||||||
2025-12-30 | CUE | Cue Biopharma, Inc. | Sarraf Pasha | Dir | P - Purchase | $0.31 | +323,857 | 323,857 | New | +$99,747 | ||||||
| M | 2025-12-30 | ONFO | Onfolio Holdings, Inc | Wells Dominic Benjamin James | CEO, CRO, Chair of Board, 10% | P - Purchase | $0.67 | +74,500 | 1,240,000 | +6% | +$49,713 | |||||
2025-12-29 | PROP | Prairie Operating Co. | Narrogal Nominees Pty Ltd Atf Gregory K O'Neill Family Trust | 10% | P - Purchase | $1.61 | +210,981 | 15,481,603 | +1% | +$339,806 | ||||||
| M | 2025-12-30 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.19 | +1,608,833 | 2,768,954 | +139% | +$298,862 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-05 | DRS | Leonardo Drs, Inc. | Dorfman Mark | EVP, GC, Secretary | S - Sale | $37.00 | -7,680 | 27,680 | -22% | -$284,160 | ||||||
2026-01-05 | DRS | Leonardo Drs, Inc. | Dippold Michael | EVP, CFO | S - Sale | $37.00 | -10,588 | 42,952 | -20% | -$391,756 | ||||||
| DM | 2026-01-05 | KTOS | Kratos Defense & Security Solutions, Inc. | Demarco Eric M | Pres, CEO | S - Sale+OE | $90.27 | -200,000 | 749,320 | -21% | -$18,053,805 | |||||
2026-01-02 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | CEO | S - Sale | $30.68 | -15,000 | 671,907 | -2% | -$460,134 | ||||||
| D | 2026-01-02 | WVE | Wave Life Sciences Ltd. | Francis Chris | See Remarks | S - Sale+OE | $16.03 | -9,375 | 25,000 | -27% | -$150,260 | |||||
| D | 2026-01-05 | ANAB | Anaptysbio, Inc | Faga Daniel | Pres, CEO | S - Sale+OE | $43.26 | -15,309 | 458,139 | -3% | -$662,267 | |||||
| D | 2026-01-05 | ANAB | Anaptysbio, Inc | Mulroy Dennis | CFO | S - Sale+OE | $43.26 | -3,363 | 14,330 | -19% | -$145,483 | |||||
2026-01-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $228.95 | -2,951 | 123,499 | -2% | -$675,621 | ||||||
2026-01-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $229.08 | -3,848 | 136,568 | -3% | -$881,482 | ||||||
| D | 2026-01-05 | ANAB | Anaptysbio, Inc | Lizzul Paul F. | Chief Medical Officer | S - Sale+OE | $43.26 | -4,219 | 33,303 | -11% | -$182,514 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-06 | TMP | Tompkins Financial Corp | Lee Angela B | Dir | A - Grant | $72.20 | +291 | 1,513 | +24% | +$21,011 | ||||||
2026-01-06 | TMP | Tompkins Financial Corp | Johnson Patricia A | Dir | A - Grant | $72.20 | +251 | 6,498 | +4% | +$18,123 | ||||||
2026-01-05 | HURN | Huron Consulting Group Inc. | Zumwalt Debra | Dir | S - Sale | $170.89 | -170 | 26,469 | -1% | -$29,051 | ||||||
2026-01-05 | HURN | Huron Consulting Group Inc. | Singh-Bushell Ekta | Dir | S - Sale | $170.89 | -126 | 14,215 | -1% | -$21,532 | ||||||
2026-01-05 | HURN | Huron Consulting Group Inc. | Sawyer Hugh E III | Dir | S - Sale | $170.89 | -136 | 21,390 | -1% | -$23,241 | ||||||
| AD | 2026-01-02 | WLFC | Willis Lease Finance Corp | Dameron Clifton | SVP, GC, Corporate Secretary | A - Grant | $134.12 | +4,474 | 12,336 | +57% | +$600,053 | |||||
| AD | 2026-01-02 | WLFC | Willis Lease Finance Corp | Dameron Clifton | SVP, GC, Corporate Secretary | F - Tax | $134.12 | -320 | 12,336 | -3% | -$42,918 | |||||
2026-01-05 | DRS | Leonardo Drs, Inc. | Wallace Sally | EVP, COO | S - Sale | $35.17 | -1,300 | 58,353 | -2% | -$45,721 | ||||||
2026-01-05 | DRS | Leonardo Drs, Inc. | Dorfman Mark | EVP, GC, Secretary | S - Sale | $37.00 | -7,680 | 27,680 | -22% | -$284,160 | ||||||
2026-01-05 | DRS | Leonardo Drs, Inc. | Dippold Michael | EVP, CFO | S - Sale | $37.00 | -10,588 | 42,952 | -20% | -$391,756 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |